P2 T cells were also within closer proximity to melanoma cells in patients with no recurrence, and alongside P1 (CD39+CD103+PD-1+) it was more likely to localize at the infiltrating face of the tumor margin. The gene discussed is ENTPD1; the disease is melanoma.